Intrinsic Value of S&P & Nasdaq Contact Us

VYNE Therapeutics Inc. VYNE NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.75
+823.1%

VYNE Therapeutics Inc. (VYNE) has 12 identified peers for comparison in the Healthcare sector. Peers include AKTX, AXLA, BCEL, CBIO, CDTX, FWBI and others.

VYNE has a market capitalization of $10.38M, compared to an average peer market cap of $525.19M. VYNE is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message